Home Tanox

Tanox

acquired
IPO
Monoclonal Antibody Drug Developer
Basic
Enterprise Profile

Basic Information

Tanox is a biotechnology company specializing in the discovery and development of biotherapeutic drugs based on monoclonal antibody technology.
Tanox, Inc.
Houston,Texas,United States of America
101~500 people
January 01, 1986
--
--

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Technology
Gene Technology Biotechnology
Concept
Support Departments Disease Treatment
Application Scenarios
Innovative Drugs Monoclonal Antibody